Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Teva, Active Biotech halt higher doses of oral MS drug in trials

 

Teva, Active Biotech halt higher doses of oral MS drug in trials

2016-01-04 16:59:51| Biotech - Topix.net

Teva Pharmaceutical Industries and Active Biotech will discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients. Both trials of laquinimod will continue with the lower dose of 0.6 mg daily where there were no issues.

Tags: active higher drug oral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

01.11 Boeing makes 38% pay rise offer in bid to end strike 01.11 The house paints that promise much more than colour 01.11 Eastern North Pacific Tropical Weather Outlook 01.11 Atlantic Tropical Weather Outlook 01.11 Technology adoption: What's on the ag tech horizon for 2025 01.11 Technology adoption: What's on the ag tech horizon for 2025 01.11 How Japan's youngest CEO transformed Hello Kitty 31.10 Unicharm to Expand in Africa More »